Log in

TRACON Pharmaceuticals News Headlines (NASDAQ:TCON)

$3.66
+0.39 (+11.93 %)
(As of 11/21/2019 01:38 AM ET)
Today's Range
$3.17
Now: $3.66
$3.67
50-Day Range
$0.30
MA: $1.08
$3.85
52-Week Range
$2.78
Now: $3.66
$17.30
Volume36,500 shs
Average Volume30,355 shs
Market Capitalization$11.49 million
P/E RatioN/A
Dividend YieldN/A
Beta2.28

Headlines

TRACON Pharmaceuticals (NASDAQ TCON) News Headlines

Source:
DateHeadline
Zacks: Brokerages Expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Announce -$1.57 Earnings Per ShareZacks: Brokerages Expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Announce -$1.57 Earnings Per Share
www.americanbankingnews.com - November 14 at 8:28 PM
TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Post FY2019 Earnings of ($7.60) Per Share, Jefferies Financial Group ForecastsTRACON Pharmaceuticals Inc (NASDAQ:TCON) to Post FY2019 Earnings of ($7.60) Per Share, Jefferies Financial Group Forecasts
www.americanbankingnews.com - November 11 at 1:47 AM
Edited Transcript of TCON earnings conference call or presentation 5-Nov-19 9:30pm GMTEdited Transcript of TCON earnings conference call or presentation 5-Nov-19 9:30pm GMT
finance.yahoo.com - November 9 at 2:28 PM
FY2020 EPS Estimates for TRACON Pharmaceuticals Inc (NASDAQ:TCON) Reduced by Jefferies Financial GroupFY2020 EPS Estimates for TRACON Pharmaceuticals Inc (NASDAQ:TCON) Reduced by Jefferies Financial Group
www.americanbankingnews.com - November 8 at 9:32 PM
TCON TRACON Pharmaceuticals, Inc. Common StockTCON TRACON Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - November 8 at 1:20 PM
Tracon Pharma reverse splits shares 1:10Tracon Pharma reverse splits shares 1:10
seekingalpha.com - November 8 at 1:20 PM
TRACON Pharmaceuticals Announces Reverse Stock SplitTRACON Pharmaceuticals Announces Reverse Stock Split
finance.yahoo.com - November 8 at 8:20 AM
TRACON Pharmaceuticals (TCON) Buy Rating Reaffirmed at HC WainwrightTRACON Pharmaceuticals' (TCON) Buy Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - November 7 at 10:51 AM
TRACON Pharmaceuticals (NASDAQ:TCON) Issues  Earnings Results, Beats Expectations By $0.03 EPSTRACON Pharmaceuticals (NASDAQ:TCON) Issues Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - November 6 at 8:12 PM
TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q3 2019 Results - Earnings Call TranscriptTRACON Pharmaceuticals' (TCON) CEO Charles Theuer on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 11:41 PM
TRACON Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateTRACON Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 5 at 6:40 PM
TRACON Pharmaceuticals (TCON) to Release Quarterly Earnings on TuesdayTRACON Pharmaceuticals (TCON) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 30 at 12:59 PM
TRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019TRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019
finance.yahoo.com - October 29 at 11:24 PM
TRACON Pharmaceuticals announces stock purchase up to $15M with Aspire Capital FundTRACON Pharmaceuticals announces stock purchase up to $15M with Aspire Capital Fund
seekingalpha.com - October 21 at 12:26 PM
TRACON Pharmaceuticals Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLCTRACON Pharmaceuticals Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
finance.yahoo.com - October 21 at 12:26 PM
Tracon Pharmaceuticals IncTracon Pharmaceuticals Inc
www.bloomberg.com - October 19 at 12:48 AM
TRACON Pharmaceuticals Announces that Scientific Advisor William Kaelin, Jr., M.D. was Awarded the 2019 Nobel Prize in Physiology or MedicineTRACON Pharmaceuticals Announces that Scientific Advisor William Kaelin, Jr., M.D. was Awarded the 2019 Nobel Prize in Physiology or Medicine
finance.yahoo.com - October 7 at 5:37 PM
TRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. WainwrightTRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
finance.yahoo.com - September 3 at 8:51 AM
TRACON Pharmaceuticals to Present at the 2019 Wells Fargo Securities Healthcare ConferenceTRACON Pharmaceuticals to Present at the 2019 Wells Fargo Securities Healthcare Conference
finance.yahoo.com - August 29 at 8:52 AM
TRACON Pharmaceuticals to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed SmithTRACON Pharmaceuticals to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith
finance.yahoo.com - August 28 at 12:01 PM
TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q2 2019 Results - Earnings Call TranscriptTRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 11:08 PM
TRACON Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateTRACON Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 11:08 PM
TRACON Pharmaceuticals to Participate in the 2019 BTIG Biotechnology ConferenceTRACON Pharmaceuticals to Participate in the 2019 BTIG Biotechnology Conference
finance.yahoo.com - August 7 at 9:24 AM
I-Mab BiopharmaI-Mab Biopharma
www.benzinga.com - August 2 at 12:45 AM
I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1
www.nasdaq.com - August 1 at 9:06 AM
I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of the CD73 Antibody TJD5 in Patients with Advanced Solid TumorsI-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of the CD73 Antibody TJD5 in Patients with Advanced Solid Tumors
finance.yahoo.com - August 1 at 9:06 AM
TRACON to Report Second Quarter 2019 Company Highlights and Financial Results on August 7, 2019TRACON to Report Second Quarter 2019 Company Highlights and Financial Results on August 7, 2019
finance.yahoo.com - July 31 at 11:54 PM
TRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access DayTRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access Day
finance.yahoo.com - July 29 at 11:23 AM
TRACON Pharmaceuticals Inc.TRACON Pharmaceuticals Inc.
www.barrons.com - July 9 at 6:42 PM
TRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate CancerTRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate Cancer
finance.yahoo.com - July 2 at 8:23 AM
Is TRACON Pharmaceuticals, Inc.'s (NASDAQ:TCON) Balance Sheet A Threat To Its Future?Is TRACON Pharmaceuticals, Inc.'s (NASDAQ:TCON) Balance Sheet A Threat To Its Future?
finance.yahoo.com - June 27 at 6:48 PM
What Kind Of Shareholders Own TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)?What Kind Of Shareholders Own TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)?
finance.yahoo.com - June 9 at 8:42 AM
TRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare ConferenceTRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 30 at 8:29 AM
Edited Transcript of TCON earnings conference call or presentation 14-May-19 8:30pm GMTEdited Transcript of TCON earnings conference call or presentation 14-May-19 8:30pm GMT
finance.yahoo.com - May 15 at 8:58 PM
TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q1 2019 Results - Earnings Call TranscriptTRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 8:30 AM
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate UpdateTRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
www.globenewswire.com - May 14 at 8:00 PM
TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019
finance.yahoo.com - May 7 at 6:59 PM
Nanocap Biotech Tracon Falls 50% After Shelving StudyNanocap Biotech Tracon Falls 50% After Shelving Study
www.benzinga.com - April 13 at 8:59 AM
Bad news for Apple, Tracon slides, Boeing completes test flightsBad news for Apple, Tracon slides, Boeing completes test flights
finance.yahoo.com - April 12 at 8:30 PM
TRACON Pharma down 47% after termination of late-stage TAPPAS trialTRACON Pharma down 47% after termination of late-stage TAPPAS trial
seekingalpha.com - April 12 at 8:20 AM
TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring CommitteeTRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee
finance.yahoo.com - April 12 at 8:20 AM
Tracon Pharmaceuticals shares slide 45% premarket after it ends trial of cancer treatmentTracon Pharmaceuticals shares slide 45% premarket after it ends trial of cancer treatment
finance.yahoo.com - April 12 at 8:20 AM
TRACON Pharmaceuticals Announces TRC105, TRC253 and TRC102 Data Presentations at Upcoming AACR Annual MeetingTRACON Pharmaceuticals Announces TRC105, TRC253 and TRC102 Data Presentations at Upcoming AACR Annual Meeting
finance.yahoo.com - March 27 at 8:27 AM
How Should Investors React To TRACON Pharmaceuticals, Inc.’s (NASDAQ:TCON) CEO Pay?How Should Investors React To TRACON Pharmaceuticals, Inc.’s (NASDAQ:TCON) CEO Pay?
finance.yahoo.com - March 7 at 7:30 PM
Edited Transcript of TCON earnings conference call or presentation 28-Feb-19 9:30pm GMTEdited Transcript of TCON earnings conference call or presentation 28-Feb-19 9:30pm GMT
finance.yahoo.com - March 2 at 6:21 PM
TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q4 2018 Results - Earnings Call TranscriptTRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 1 at 8:41 AM
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update - GlobeNewswireTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update - GlobeNewswire
globenewswire.com - February 28 at 7:04 PM
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate UpdateTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - February 28 at 7:04 PM
TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019
finance.yahoo.com - February 21 at 6:58 PM
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular CarcinomaTRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma
finance.yahoo.com - January 22 at 6:23 PM
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Featured Article: Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel